secwatch.observer — SEC 8-K summary
======================================

Issuer:     IONIS PHARMACEUTICALS INC (IONS)
CIK:        0000874015
Form:       8-K
Filed at:   2024-02-29T23:59:59+00:00
Accession:  0001140361-24-010288
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ionis announces Kyle Jenné returns as EVP Commercial; Onaiza Cadoret-Manier departs
--------------------------------------------------------------------------------

- Kyle Jenné rejoins as executive vice president, commercial, effective Feb 29, 2024.
- Onaiza Cadoret-Manier, EVP chief global product strategy and operations officer, leaves for another opportunity.
- Cadoret-Manier will remain full-time through March 15, 2024, then serve as advisor.
- Advisory agreement pays $12,500/month through Sep 2024, then $6,250/month through Jan 10, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/874015/000114036124010288/0001140361-24-010288-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/874015/000114036124010288/ef20022767_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-010288

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer